loader2
Partner With Us NRI

Makers Laboratories Ltd share Price Today

Company details

133.10
136.25
94.00
157.00
6M Return 20.38%
1Y Return 34.03%
Mkt Cap.(Cr) 79.12
Volume 2,994
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 2,994

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Makers Laboratories Ltd shares SWOT Analysis

Strengths (3)

  • Company with Low Debt
  • Increasing Revenue every quarter for the past 2 quarters
  • Company with Zero Promoter Pledge

Weakness (1)

  • Low Piotroski Score : Companies with weak financials

Opportunity (1)

  • Stock with Low PE (PE < = 10)

Threats (0)

Data not found

Resistance and support

R1 141.7
R2 147.0
R3 151.0
Pivot

137.65

S1 132.3
S2 128.3
S3 123.0
EMA SMA
135.2
132.6
127.1
123.1
133.8
137.1
123.8
117.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
MANJU SINGHI Bulk Sell 2023-03-13 105.75 29562 BSE
VINAR NIRYAT PRIVATE LIMITED Bulk Purchase 2020-11-23 138.76 46250 BSE
VARA LAKSHMI G Bulk Sell 2020-11-23 139.5 59149 BSE
Name Category Shares
Premchand Godha PROMOTER 2.15%
Prashant Godha PROMOTER 2.08%
Nirmal Gigalal Jain PROMOTER 1.62%
Usha Premchand Godha PROMOTER 0.97%
Bhawna Godha PROMOTER 0.72%
Usha M Chandurkar PROMOTER 0.69%
Kaygee Investments Private Limited PROMOTER 17.38%
Paschim Chemicals Pvt Ltd PROMOTER 16.38%
Kaygee Laboratories Private Limited PROMOTER 14.35%
Mexin Medicaments Private Limited PROMOTER 3.12%
Chandurkar Investments Private Limited PROMOTER 1.43%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Makers Laboratories Ltd Stocks COMPARISON

Financials( in Cr) Makers Laboratories Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Zydus Lifesciences Ltd
Price 134.10 1,556.95 1,469.85 6,440.75 942.55
% Change -1.61 -0.28 0.24 -0.02 2.09
Mcap Cr 79.12 373,564.46 118,668.34 107,437.51 95,405.29
Revenue TTM Cr 101.28 43,885.68 15,790.60 24,669.70 17,237.40
Net Profit TTM Cr -2.19 8,560.84 2,513.47 4,507.30 1,997.30
PE TTM 0.00 39.93 29.93 20.56 27.98
1 Year Return 34.03 60.10 53.06 44.75 101.46
ROCE 1.60 16.79 14.76 25.99 16.25
ROE -3.40 16.46 10.66 21.21 14.05
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 69.20 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 20,723.19 -6,502.89
LAST 3M 66,180.77 -20,510.57
LAST 6M 121,980.03 9,662.75
LAST 12M 182,040.92 177,457.32

Makers Laboratories Ltd Information

Stock PE (TTM)
0
Promoter Holding
61.27%
Book Value
111.4207
ROCE
1.6%
ROE
-3.4%
Description
  • Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company is presently in manufacture of pharmaceutical formulations and drug intermediates. Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993. As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL. During 1996-97, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit. MLL has gone for expansion in the year 1999. It has increased the installed capacity of Tablets & Capsules by 13.25 crores(Nos) and the company has again expanded the installed capacity of Tablets & Capsules in the year 2000 by 15.00 crores(Nos),taking the total capacity to 60.00 crores. The Modernisation of Formulation Drugs which was undertaken during 1999-2000 was completed successfully and this project was financed through Rights Issue of Equity Shares. The Palghar Plant Liquid Department was upgraded under the standard of schedule `M` during 2004. The Company sold its unviable formulations manufacturing unit at Palghar, in Thane Dist. during 2008. Harleystreet Pharmaceuticals Ltd. was merged with the Company by a Scheme of Amalgamation during the period 2011. In terms of the said Scheme of Amalgamation, 571,440 Equity shares of the Company of Rs 10/- each fully paid up were issued to the shareholders of HPL in the ratio of 6 fully paid up equity shares of Rs. 10/- each of the Company for every 10 fully paid up equity shares of Rs. 10/- each of HPL. i.e., 6:10. The Company sold its bulk drugs manufacturing unit at Dombivili, in Thane Dist. during the year 2016-17. It launched a new range of Diabetic & Hypertensive drugs including Voglibose, Gli-me range (Glimepiride Metformin Pioglitazone), Hypernorm range (Telmisartan). The Company further acquired 52,50,000 Equity shares of Rs 10/- each of Resonance Specialties Limited and became its subsidiary effective from 11th December, 2020. During 2020-21, the Company started manufacturing new ophthalmic eye drops at Naroda, in Ahmedabad in February, 2021. It started work on upgradation / modernization/capacity enhancement of its old liquid injectable manufacturing unit at Naroda, Gujarat in January, 2022.

Registered Address

54 D Kandivli Industrial Estat, Charkop Kandivli (West), Mumbai, Maharashtra, 400067

Tel : 91-22-2868 8544
Email : investors:makerslabs.com
Website : http://www.makerslabs.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 506919
NSE Code :
Book Closure Date (Month) :
BSE Group : X
ISIN : INE987A01010

FAQ’s on Makers Laboratories Ltd Shares

You can buy Makers Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Makers Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 26, 2024 04:01 PM the closing price of Makers Laboratories Ltd was ₹ 134.10.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Feb 26, 2024 04:01 PM, the market cap of Makers Laboratories Ltd stood at ₹ 79.12.

The latest PE ratio of Makers Laboratories Ltd as of Feb 26, 2024 04:01 PM is 0

The latest PB ratio of Makers Laboratories Ltd as of Feb 26, 2024 04:01 PM is 0.82

The 52-week high of Makers Laboratories Ltd is ₹ 157.00 while the 52-week low is ₹ 94.00

Download Our

Download App
market app